inside the rapidly evolving subject of oncology analysis, accurate and economical mutation screening is essential for building focused therapies. The KRAS providers Platform plays a pivotal role On this landscape by offering in depth methods for KRAS mutation profiling and Examination. KRAS mutations, found in about ninety five% of RAS-associated o